6th Rare Genetic Kidney Disease Drug Development Summit to Address Key Challenges in Boston
The 6th Rare & Genetic Kidney Disease Drug Development Summit is set to take place in Boston from August 18-20, 2026. This event will gather global leaders in the field of rare and inherited renal disorders to discuss the scientific, clinical, and regulatory challenges in kidney drug development. The summit will focus on adaptive platform trials, external control arms, and the use of natural history data to reduce patient burden. It aims to provide a collaborative environment for experts from biopharma, academia, regulators, and patient advocacy organizations to share insights and strategies. Key topics include regulatory alignment, biomarker and endpoint validation, and adaptive trial design. The summit will feature speakers from major pharmaceutical companies and will include interactive workshops to strengthen commercial strategies. 
